| Trial ID: | L1463 |
| Source ID: | NCT05540431
|
| Associated Drug: |
Activated Charcoal
|
| Title: |
Evaluation of Protective Effect of Activated Charcoal and Probiotic Against Progression of Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Uremic Toxin
|
| Interventions: |
DRUG: Activated Charcoal|DIETARY_SUPPLEMENT: Probiotic|OTHER: No intervention
|
| Outcome Measures: |
Primary: Improving of blood urea, The concentration of blood urea(mmol/L),dL) ) in all blood samples, Baseline to 6 week|Indoxyl sulfate assay, The concentration of human indoxyl sulfates level by elisa technique in the subjects' blood samples, Baseline to 6 week|Improving of serum creatinine mg/dL, The concentration of serum creatinine(mg/dL) in all blood sample, Baseline to 6 week | Secondary: Nutrition status, The concentration of albumin(g/dL) in the subjects' blood samples, Baseline to 6 week
|
| Sponsor/Collaborators: |
Sponsor: Waleed Khaild Rahman Kareem Al-kabi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
|
| Start Date: |
2022-09-25
|
| Completion Date: |
2023-12-20
|
| Results First Posted: |
|
| Last Update Posted: |
2022-09-14
|
| Locations: |
Waleed Khaild Rahman Alkabi, Al-diwanyia, Iraq
|
| URL: |
https://clinicaltrials.gov/show/NCT05540431
|
